Literature DB >> 5806435

Clinical and laboratory studies on the action of desferrioxamine.

R L Cumming, J A Millar, J A Smith, A Goldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5806435     DOI： 10.1111/j.1365-2141.1969.tb01371.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Total management of thalassaemia major.

Authors:  B Modell
Journal:  Arch Dis Child       Date:  1977-06       Impact factor: 3.791

2.  Urinary iron excretion in thalassaemia after desferrioxamine administration.

Authors:  R Seshadri; J H Colebatch; R Fisher
Journal:  Arch Dis Child       Date:  1974-03       Impact factor: 3.791

3.  High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis.

Authors:  H Breithaupt; H Heckers; H Pralle; W Guttmann; H Bleyl; V Graef; G Jundt
Journal:  Blut       Date:  1986-04

4.  Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload.

Authors:  G E Janka; P Möhring; M Helmig; R J Haas; K Betke
Journal:  Eur J Pediatr       Date:  1981-11       Impact factor: 3.183

5.  Iron overload and desferrioxamine chelation therapy in beta-thalassemia intermedia.

Authors:  P Cossu; C Toccafondi; F Vardeu; G Sanna; F Frau; R Lobrano; G Cornacchia; A Nucaro; F Bertolino; A Loi; S De Virgiliis; A Cao
Journal:  Eur J Pediatr       Date:  1981-11       Impact factor: 3.183
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.